Showing results (281-290 of 432) with videos related to

Sort By:
Pageof 44
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2014
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014), Juan Berenguer, Rosa Polo, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2007
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosisEsteban Ribera, Carlos Azuaje, Rosa M Lopez, et al.
AIDS Research and Human Retroviruses|July 14, 2010
Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trialJosé M Miró, Christian Manzardo, Judith Pich, et al.
AIDS (London, England)|December 6, 2024
Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic IslandsAndreu Bruguera, Daniel K Nomah, Sergio Moreno-Fornés, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|October 5, 2010
[Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy]Josep M Llibre, Antonio Antela, José Ramón Arribas, et al.
Current HIV Research|November 26, 2009
Risk factors, CD4 long-term evolution and mortality of HIV-infected patients who persistently maintain low CD4 counts, despite virological response to HAARTYolanda M Pacheco, Inmaculada Jarrín, Julia Del Amo, et al.
Journal of the International AIDS Society|November 15, 2014
Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patientsDaniel Podzamczer, Jhon Fredy Rojas, Isabel Neves, et al.
The Lancet. Infectious Diseases|December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trialGeorg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
Antiviral Therapy|February 1, 2012
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week studyJosep M Llibre, Maria J Buzón, Marta Massanella, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretroviralsArkaitz Imaz, Josep M Llibre, Marta Mora, et al.
Pageof 44